title: Ganciclovir-resistant cytomegalovirus infection in transplanted patients: utility of drug monitoring.
authors.forename: P
authors.initials: P
authors.lastname: Esposito
authors.forename: G
authors.initials: G
authors.lastname: Bedino
authors.forename: F
authors.initials: F
authors.lastname: Montagna
authors.forename: M
authors.initials: M
authors.lastname: Gregorini
authors.forename: T
authors.initials: T
authors.lastname: Rampino
authors.forename: A
authors.initials: A
authors.lastname: Dal Canton
mesh_terms: D003587:Cytomegalovirus / Q000235:genetics*; D003586:Cytomegalovirus Infections / Q000209:etiology*; D015774:Ganciclovir / Q000494:pharmacology*; D016027:Heart Transplantation / Q000009:adverse effects*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000235:genetics*
chemical_list: D017853:Phosphotransferases (Alcohol Group Acceptor); D015774:Ganciclovir